Emerging Phage-encoded Endolysins to Combat Multidrug-resistant to Boon Prevent Surgical Site Infection
Overview
Overview
Journal
Ann Med Surg (Lond)
Publisher
Wolters Kluwer
Specialty
Medical Education
Date
2024 Dec 9
PMID
39649922
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Mancuso G, Midiri A, Gerace E, Biondo C
. Bacterial Antibiotic Resistance: The Most Critical Pathogens. Pathogens. 2021; 10(10).
PMC: 8541462.
DOI: 10.3390/pathogens10101310.
View
2.
An N, Hai L, Luong V, Vinh N, Hoa P, Hung L
. Antimicrobial Resistance Patterns of Staphylococcus Aureus Isolated at a General Hospital in Vietnam Between 2014 and 2021. Infect Drug Resist. 2024; 17:259-273.
PMC: 10822110.
DOI: 10.2147/IDR.S437920.
View
3.
Rahman M, Wang W, Sun Q, Shah J, Li C, Sun Y
. Endolysin, a Promising Solution against Antimicrobial Resistance. Antibiotics (Basel). 2021; 10(11).
PMC: 8614784.
DOI: 10.3390/antibiotics10111277.
View
4.
Murray E, Draper L, Ross R, Hill C
. The Advantages and Challenges of Using Endolysins in a Clinical Setting. Viruses. 2021; 13(4).
PMC: 8071259.
DOI: 10.3390/v13040680.
View
5.
Khan F, Rasheed F, Yang Y, Liu B, Zhang R
. Endolysins: a new antimicrobial agent against antimicrobial resistance. Strategies and opportunities in overcoming the challenges of endolysins against Gram-negative bacteria. Front Pharmacol. 2024; 15:1385261.
PMC: 11144922.
DOI: 10.3389/fphar.2024.1385261.
View